Thyrotoxic periodic paralysis mimicking hypokalemic periodic paralysis

  • Authors

    • Dr. Vivek Chaudhari GMERS Medical College and Hospital, Himmatnagar
    • Dr. Harshvardhansinh Chauhan GMERS Medical College and Hospital, Himmatnagar
    • Dr. Manisha Panchal GMERS Medical College and Hospital, Himmatnagar
  • Endocrinology, Hyperthyroidism, Hypokalaemia, Hypokalemic periodic paralysis, Reversible cause of muscle weakness
  • Thyrotoxic periodic paralysis is a unique disorder that causes episodic proximal lower extremity muscle weakness in a patient who already has a hyperthyroid state and is not treated for the underlying disease state. The affected population mostly includes Asian in origin specifically the male gender (vs most thyroid disorder affects the women gender). Precipitating factors include in addition to a hyperthyroid state are strenuous exertion, a high-carbohydrate meal, and drugs like diuretics, insulin, high dose of steroids, antiretrovirals, and interferon therapy. Other genetic causes include the decreased activity of Kir2.6 mutation increased activity of Na+/K+ ATPase causing an intracellular shift of potassium that leads to hypokalaemia. The other challenging part for the physician is to differentiate it from Familial periodic paralysis an autosomal disorder seen in Caucasians and Western countries because both the disorders present similarly and differentiate between them by the presence of hyperthyroid state with hypokalaemia in Thyrotoxic periodic paralysis. The mortality is associated with respiratory paralysis hence the acute intervention includes giving nonselective beta-blockers followed by anti-thyroid medications. We present a case of an Indian adolescent who presented to us with lower muscle weakness with an underlying thyrotoxicosis state. This help physician with early diagnosis and appropriate treatment.




  • References

    1. [1] Chang CC, Cheng CJ, Sung CC, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol. 2013; 169(5):529-536. Published 2013 Oct 1.

      [2] Lin SH, Lin YF, Chen DT, Chu P, Hsu CW & Halperin ML.Laboratory tests to determine the cause of hypokalemia and paralysis. Archives of Internal Medicine 2004 164 156 -1566. 6.

      [3] Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy. Am J Emerg Med. 1992 Mar; 10(2):143-8.

      [4] Lam L, Nair RJ, Tingle L. Thyrotoxic periodic paralysis. Proc (Bayl Univ Med Cent). 2006; 19(2):126-129.

      [5] Vijayakumar A, Ashwath G, Thimmappa D. Thyrotoxic periodic paralysis: clinical challenges. J Thyroid Res. 2014; 2014:649502. Epub 2014 Feb 20. Retraction in: J Thyroid Res. 2021 Mar 16; 2021:7814159.

      [6] Magsino CH Jr, Ryan AJ Jr. Thyrotoxic periodic paralysis. South Med J. 2000 Oct; 93(10):996-1003. PMID: 11147484.

      [7] McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J. 1967; 1(5538):451-455.

      [8] Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc. 2005 Jan; 80(1):99-105.

      [9] Ryan DP, da Silva MR, Soong TW, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010; 140(1):88-98.

      [10] Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999 Mar 22; 159(6):601-6.

  • Downloads

  • How to Cite

    Vivek Chaudhari, D., Harshvardhansinh Chauhan, D., & Manisha Panchal, D. (2022). Thyrotoxic periodic paralysis mimicking hypokalemic periodic paralysis. International Journal of Medicine, 10(1), 1-2.